Orchestra BioMed Holdings Inc (NASDAQ: OBIO) kicked off on Tuesday, up 15.38% from the previous trading day, before settling in for the closing price of $2.6. Over the past 52 weeks, OBIO has traded in a range of $2.37-$7.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -273.68%. While this was happening, its average annual earnings per share was recorded -14.34%. With a float of $42.19 million, this company’s outstanding shares have now reached $53.96 million.
Orchestra BioMed Holdings Inc (OBIO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Orchestra BioMed Holdings Inc is 21.80%, while institutional ownership is 34.92%. The most recent insider transaction that took place on Aug 25 ’25, was worth 15,034. In this transaction Director of this company bought 5,760 shares at a rate of $2.61, taking the stock ownership to the 71,709 shares. Before that another transaction happened on Aug 25 ’25, when Company’s insider bought 3,000 for $2.62, making the entire transaction worth $7,860. This insider now owns 926,837 shares in total.
Orchestra BioMed Holdings Inc (OBIO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.41 earnings per share (EPS), higher than consensus estimate (set at -0.44) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.76% during the next five years compared to -273.68% drop over the previous five years of trading.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Take a look at Orchestra BioMed Holdings Inc’s (OBIO) current performance indicators. Last quarter, stock had a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.83, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Orchestra BioMed Holdings Inc (OBIO)
Looking closely at Orchestra BioMed Holdings Inc (NASDAQ: OBIO), its last 5-days average volume was 0.41 million, which is a jump from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 65.21%.
During the past 100 days, Orchestra BioMed Holdings Inc’s (OBIO) raw stochastic average was set at 54.31%, which indicates a significant decrease from 88.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was lower than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.90, while its 200-day Moving Average is $3.99. However, in the short run, Orchestra BioMed Holdings Inc’s stock first resistance to watch stands at $3.17. Second resistance stands at $3.35. The third major resistance level sits at $3.62. If the price goes on to break the first support level at $2.73, it is likely to go to the next support level at $2.46. Now, if the price goes above the second support level, the third support stands at $2.29.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Key Stats
The company with the Market Capitalisation of 161.86 million has total of 38,644K Shares Outstanding. Its annual sales at the moment are 2,640 K in contrast with the sum of -61,020 K annual income. Company’s last quarter sales were recorded 840 K and last quarter income was -19,360 K.
